Corbion N.V.

Amsterdam Stock Exchange CRBN.AS

Corbion N.V. Price to Sales Ratio (P/S) on January 14, 2025: 0.84

Corbion N.V. Price to Sales Ratio (P/S) is 0.84 on January 14, 2025, a 13.63% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Corbion N.V. 52-week high Price to Sales Ratio (P/S) is 1.05 on September 27, 2024, which is 26.00% above the current Price to Sales Ratio (P/S).
Corbion N.V. 52-week low Price to Sales Ratio (P/S) is 0.64 on January 19, 2024, which is -23.51% below the current Price to Sales Ratio (P/S).
Corbion N.V. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.83.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Amsterdam Stock Exchange: CRBN.AS

Corbion N.V.

CEO	Mr. Olivier Rigaud
IPO Date	March 29, 1995
Location	Netherlands
Headquarters	Piet Heinkade 127
Employees	2,727
Sector	Health Care
Industries Biotechnology

Description

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

Key trends

Past 5 years